opc 12759 has been researched along with Atrophy in 1 studies
rebamipide: structure in first source; RN refers to (+-)-isomer; inhibits gastric xanthine oxidase
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, JS | 1 |
| Jeon, SW | 1 |
| Lee, HS | 1 |
| Kwon, YH | 1 |
| Nam, SY | 1 |
| Bae, HI | 1 |
| Seo, AN | 1 |
1 trial available for opc 12759 and Atrophy
| Article | Year |
|---|---|
Rebamipide for the Improvement of Gastric Atrophy and Intestinal Metaplasia: A Prospective, Randomized, Pilot Study.
Topics: Alanine; Atrophy; Gastric Mucosa; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; | 2022 |